Related Articles
Research progress in the metabolic reprogramming of hepatocellular carcinoma (Review)
Dihydroartemisinin inhibits ATP6 activity, reduces energy metabolism of hepatocellular carcinoma cells, promotes apoptosis and inhibits metastasis via CANX
Energy metabolism determines the sensitivity of human hepatocellular carcinoma cells to mitochondrial inhibitors and biguanide drugs
Function and clinical potential of microRNAs in hepatocellular carcinoma (Review)
MicroRNA‑34a inhibits liver cancer cell growth by reprogramming glucose metabolism